Skip to content

Clinical trials

Completed Phase 2 Mesothelioma, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 2 Status: Completed Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20023
20033
20043
20054
20065
20076
20082
20092
20104
20111
20121
20131
20141
20153
20164
20172
20181
20192
20212
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Alliance for Clinical Trials in Oncology5
Swiss Cancer Institute4
European Organisation for Research and Treatment of Cancer - EORTC3
AGC Biologics S.p.A.2
Mario Negri Institute for Pharmacological Research2
Memorial Sloan Kettering Cancer Center2
SWOG Cancer Research Network2
The Netherlands Cancer Institute2
Abramson Cancer Center at Penn Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant67
Solitary Fibrous Tumor, Pleural18
Mesothelioma12
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms3
Pancreatic Neoplasms2
Sarcoma2
Small Cell Lung Carcinoma2
Adenocarcinoma, Follicular1
Adrenocortical Carcinoma1

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.